Author(s)

Fumiko Koyama¹, Kumi Suzuki²

¹Doctoral Program, Graduate School of Nursing, Osaka Medical College, Osaka, Japan.
²Faculty of Nursing, Osaka Medical College, Osaka, Japan.

The aim of this study was to identify the decision-making process of anti-cancer treatment in elderly patients with advanced lung cancer. Semi-structured interviews were conducted with 17 patients aged 70 and above to collect data on their feelings and thoughts from the time of diagnosis till they made treatment decisions. The data was analyzed using the Modified Grounded Theory Approach that was modified by Prof. Yasuhito Kinoshita. We found the process to be composed of six categories. The results showed that elderly patients with advanced lung cancer were panicked over unavoidable death when informed of stage IV lung cancer and offered suggestions about anti-cancer treatment. However, trying to accept the situation where death is imminent, patients reconsidered having cancer in older age and recognized a desire to survive even in older age. This process diverged into two paths: one group of patients changed their ideas from radical to life-prolonging treatment by recognizing a desire to survive even in older age and then made anti-cancer treatment decisions by carefully choosing treatment that would allow to carry on their usual way of life; the other group of patients made treatment decisions by carefully choosing physicians to whom they could entrust their life in older age. These findings suggest that it is important for nurses to: 1) encourage patients to talk in order to have them think about what they have valued and want to value in the rest of their life; 2) assess if patients prefer to decide on their own by carefully choosing treatment or entrust treatment decisions to physicians; and 3) offer support according to patients’ preferences.

Advanced Lung Cancer, Elderly, Anti-Cancer Treatment, Decision-Making

Koyama, F. and Suzuki, K. (2017) Process of Decision-Making of Anti-Cancer Treatment in Elderly Patients with Advanced Lung Cancer. Health, 9, 1644-1659. doi: 10.4236/health.2017.912121.